Woelders, Eva C. I.
Peeters, Denise A. M.
Janssen, Sanne
Luijkx, Jasper J. P.
Winkler, Patty J. C.
Damman, Peter
Remkes, Wouter S.
van ’t Hof, Arnoud W. J.
van Geuns, Robert Jan M.
,
Woelders, E. C. I.
Peeters, D. A. M.
Damman, P.
van Geuns, R. J. M.
van Royen, N.
van Wely, M. H.
Camaro, C.
ten Cate, T.
Dimitriu-Leen, A. C.
van Nunen, L. X.
Janssen, S.
Luijkx, J. J. P.
van ’t Hof, A. W. J.
Winkler, P. J. C.
Ilhan, M.
Ruiters, A. W.
Lux, A.
Stein, M.
Rasoul, S.
Theunissen, R. A. L. J.
Vainer, J.
Veenstra, L. F.
Vriesendorp, P. A.
Hoebers, L. P. C.
Kulekci, K.
Ijsselmuiden, A. J. J.
Remkes, W. S.
Aydin, S.
Rahel, B. M.
Eerens, F. L. J.
Hemradj, V. V.
Article History
Accepted: 15 January 2025
First Online: 6 February 2025
Conflict of interest
: P.J.C. Winkler has received an unrestricted grant from Boehringer Ingelheim. P. Damman has received research grants from Abbott, Philips and AstraZeneca and is a deputy editor of the Netherlands Heart Journal. A.W.J. van ’t Hof has received unrestricted grants from AstraZeneca, Medtronic, Abbott Vascular and Boehringer Ingelheim and is an associate editor of the Netherlands Heart Journal. R.J.M. van Geuns has received grants and personal fees from Boston Scientific, Abbott Vascular, AstraZeneca and Amgen and grants from Infraredx. The other authors report no competing interests or disclosures. E.C. I. Woelders, D.A. M. Peeters, S. Janssen, J.J. P. Luijkx and W.S. Remkes declare that they have no competing interests.